Jump Financial’s IDEAYA Biosciences IDYA Stock Holding History

Jump Financial’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Buy	+56,109	New	+$1.72M	0.02%	874
2025 Q4	–	Sell	-29,360	Closed	-$799K	–	2105
2025 Q3	$799K	Buy	29,360 +8,859	+43%	+$214K	0.01%	1107
2025 Q2	$431K	Sell	20,501 -118,354	-85%	-$2.27M	﹤0.01%	1292
2025 Q1	$2.27M	Buy	138,855 +23,953	+21%	+$510K	0.03%	542
2024 Q4	$2.95M	Buy	114,902 +45,035	+64%	+$1.27M	0.06%	397
2024 Q3	$2.21M	Sell	69,867 -39,270	-36%	-$1.49M	0.05%	479
2024 Q2	$3.83M	Buy	+109,137	New	+$4.32M	0.08%	326
2024 Q1	–	Sell	-6,045	Closed	-$215K	–	2060
2023 Q4	$215K	Buy	+6,045	New	+$180K	0.01%	1524
2021 Q1	–	Sell	-11,800	Closed	-$165K	–	1092
2020 Q4	$165K	Buy	+11,800	New	+$160K	0.03%	813

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jump Financial's IDYA Position: Q2 2026 in Review

Jump Financial opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 56,109 shares worth $2.09M. The stake represents 0.02% of the portfolio and ranks #874 among its holdings. This is a return to the name: Jump Financial previously reported a position in IDYA as recently as Q3 2025.

Jump Financial first reported a position in IDYA in Q4 2020 and has held it in 9 quarters since. The position peaked at $3.83M in Q2 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Jump Financial held 56,109 shares of IDEAYA Biosciences worth $2.09M as of Q2 2026.
IDEAYA Biosciences was a new Jump Financial position in Q2 2026.
IDEAYA Biosciences made up 0.02% of Jump Financial's portfolio in Q2 2026, its #874 holding.
Jump Financial first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 9 quarters since.
Jump Financial's IDEAYA Biosciences position peaked at $3.83M in Q2 2024.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.